FDAの有害事象報告システムに基づく薬物関連レイノード症候群に関する包括的な研究

Pingping Zheng¹, Xiulian Zheng², Qun Chen³

¹First School of Clinical Medicine, Fujian University of Chinese Medicine, Fuzhou, China.

Scientific reports

|September 1, 2025

まとめ

この研究では,レイノード症候群に関連した 562 種類の薬が特定されました.

科学分野:

薬用警戒について
薬物安全性
臨床薬理学

背景:

レイノ現象 (RP),特に二次RPは,薬によって誘発または悪化することがあります.
薬物に関連したRPを特定することは,予防と管理に不可欠です.

研究の目的:

FDAの有害事象報告システム (FAERS) を使用して,レイノーの現象との薬物関連性を体系的に評価する.
RPに関連した薬物のリスクを定量化し,特定の薬剤のクラスと指示を特定する.

主な方法:

RPに関連した薬物を特定するためのFAERSデータの不均衡性分析.
アナトミック・セラピー・ケミカル (ATC) による分類
記述的および二次的な分析,時間的なパターンのワイブル形状パラメータテストを含む.

主要な成果:

562の薬物と4303のRP症例が特定されました.
神経系,心血管系,免疫調節剤で顕著な関連性が見られた.
CGRP阻害剤,トリプトン,ベータブロッカー,インターフェロン,抗新生剤は高い関連性を示した.
常連症候群は,関節リウマチ,ナルコレプシー,ADHDでした.
RPの症例は主に25~59歳の女性でした.

結論:

この研究は,薬物とRPの関連性を体系的に報告し,予防可能なリスクを強調しています.
臨床医は,CGRP阻害剤とトリプタンを含む特定の薬剤クラスでRPリスクをモニタリングする必要があります.
中年および高齢の女性,特にリウマチ性関節炎の女性では,薬剤誘発性RPに対する高度な警戒が推奨されます.

キーワード:

不釣り合い分析薬物の安全性薬物 FAERSデータベースレイノード現象

さらに関連する動画

08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

27.5K

09:42

Comprehensive Analysis of Drug Response using the FLICK Assay

Published on: June 6, 2025

377

関連する概念動画

01:19

Pharmacovigilance

983

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

983

01:25

Drug Regulation

1.8K

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

1.8K

01:21

Factors Affecting Drug Response: Overview

2.4K

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...

2.4K

01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

673

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

673

01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

3.2K

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...

3.2K

01:28

Structure-Activity Relationships and Drug Design

1.0K

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...